Immunogenicity, reactogenicity, and safety of a second booster with BNT162b2 or full-dose mRNA-1273: A randomized VACCELERATE trial in adults aged ≥75 years (EU-COVAT-1-AGED Part B)
Titel:
Immunogenicity, reactogenicity, and safety of a second booster with BNT162b2 or full-dose mRNA-1273: A randomized VACCELERATE trial in adults aged ≥75 years (EU-COVAT-1-AGED Part B)
Auteur:
Stemler, Jannik Yeghiazaryan, Lusine Stephan, Christoph Mohn, Kristin Greve-Isdahl Carcas-Sansuan, Antonio-José Rodriguez, Esperanza Romero Moltó, José Mitxeltorena, Itziar Vergara Welte, Tobias Zablockienė, Birutė Akova, Murat Bethe, Ullrich Heringer, Sarah Salmanton-García, Jon Jeck, Julia Tischmann, Lea Zarrouk, Marouan Cüppers, Arnd Biehl, Lena M. Grothe, Jan Mellinghoff, Sibylle C. Nacov, Julia A. Neuhann, Julia M. Sprute, Rosanne Frías-Iniesta, Jesús Negi, Riya Gaillard, Colette Saini, Gurvin León, Alejandro García Mallon, Patrick W.G. Lammens, Christine Hotterbeekx, An Loens, Katherine Malhotra-Kumar, Surbhi Goossens, Herman Kumar-Singh, Samir König, Franz Posch, Martin Koehler, Philipp Cornely, Oliver A.